KKR Lands $200M For New Drug Therapy Research Group
Private equity giant KKR said Tuesday it's created a drug therapy research unit that already has committed investments of $200 million and is purchasing other life sciences companies....To view the full article, register now.
Already a subscriber? Click here to view full article